GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Recursion Pharmaceuticals RXRX · USD

Health Care · US listing · 🇺🇸 United States

Compare

3.81

+8.24%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Recursion Pharmaceuticals and similar listings

Same market and sector, closest in size

Name Last closeMarket valueP/ENet marginYield Change
Recursion Pharmaceuticals RXRX 3.81$1.98bn—-863.4%— +8.24%
Pharvaris PHVS 34.47$2.25bn——— +0.23%
Stoke Therapeutics STOK 27.71$1.58bn—-3.7%— +4.41%
Nanobiotix NBTX 32.03$1.63bn—-80.8%— +4.57%
Mesoblast MESO 14.44$1.87bn—-47.8%— +1.19%
Progyny PGNY 35.95$3.10bn44.34.5%— +3.19%
Definium Therapeutics DFTX 35.39$3.16bn——— +6.37%
Syndax Pharmaceuticals SNDX 9.55$830.0m—-165.6%— +0.10%
AnaptysBio ANAB 47.97$1.38bn—-5.6%— +3.27%

Closes are in the currency each stock trades in. Blank figures mean we hold no company data for that listing yet.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.